101
Views
7
CrossRef citations to date
0
Altmetric
Review

Treatment of osteoporosis with eldecalcitol, a new vitamin D analog: a comprehensive review and meta-analysis of randomized clinical trials

, , &
Pages 509-517 | Published online: 28 Jan 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Koji Ishikawa, Takashi Nagai, Keizo Sakamoto, Kenji Ohara, Takeshi Eguro, Hiroshi Ito, Yoichi Toyoshima, Akatsuki Kokaze, Tomoaki Toyone & Katsunori Inagaki. (2016) High bone turnover elevates the risk of denosumab-induced hypocalcemia in women with postmenopausal osteoporosis. Therapeutics and Clinical Risk Management 12, pages 1831-1840.
Read now

Articles from other publishers (6)

Lijia Cui, Weibo Xia, Chuan Yu, Shuangshuang Dong & Yu Pei. (2022) Overview of the clinical efficacy and safety of eldecalcitol for the treatment of osteoporosis. Archives of Osteoporosis 17:1.
Crossref
Haichao Zhang, Zheng Ke, Shuangshuang Dong, Yanping Du, Wenjing Tang, Minmin Chen, Weijia Yu & Qun Cheng. (2022) Eldecalcitol prevents muscle loss by suppressing PI3K/AKT/FOXOs pathway in orchiectomized mice. Frontiers in Pharmacology 13.
Crossref
Saeko Fujiwara, Amy Buchanan-Hughes, Alvin Ng, Jennifer Page, Kenji Adachi & Hong Li. (2022) Real-world evaluation of osteoporotic fractures using the Japan Medical Data Vision database. Osteoporosis International 33:10, pages 2205-2216.
Crossref
太志 倉員 & 孝明 諸岡. (2022) 当院におけるロモソズマブの使用経験. Orthopedics & Traumatology 71:3, pages 558-560.
Crossref
Hongyan Liu, Guoqi Wang, Ting Wu, Yiming Mu & Weijun Gu. (2022) Efficacy and Safety of Eldecalcitol for Osteoporosis: A Meta-Analysis of Randomized Controlled Trials. Frontiers in Endocrinology 13.
Crossref
Hanxuan Li, Zhousheng Xiao, L. Darryl Quarles & Wei Li. (2021) Osteoporosis: Mechanism, Molecular Target and Current Status on Drug Development. Current Medicinal Chemistry 28:8, pages 1489-1507.
Crossref